Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
The Journal of Nutritional Biochemistry
|
May 23, 2008
Carbohydrate restriction and dietary cholesterol distinctly affect plasma lipids and lipoprotein subfractions in adult guinea pigs
Moises Torres-Gonzalez, Jose O Leite, Jeff S Volek, et al.
The Journal of Nutrition
|
January 21, 2006
Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men
Richard J Wood, Jeff S Volek, Yanzhu Liu, et al.
Clinical Chemistry
|
January 27, 2009
Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
John H Contois, Joseph P McConnell, Amar A Sethi, et al.
Circulation. Cardiovascular Quality and Outcomes
|
April 14, 2011
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk
Allan D Sniderman, Ken Williams, John H Contois, et al.
The Journal of Nutrition
|
September 22, 2006
A combination therapy including psyllium and plant sterols lowers LDL cholesterol by modifying lipoprotein metabolism in hypercholesterolemic individuals
Sudeep Shrestha, Jeff S Volek, Jay Udani, et al.
Clinical Chemistry
|
February 7, 2013
Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices
, Thomas G Cole, John H Contois, et al.
Clinical Chemistry
|
September 20, 2013
In reply
Thomas G Cole, John H Contois, Gyorgy Csako, et al.
JAMA
|
August 21, 2007
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women
Erik Ingelsson, Ernst J Schaefer, John H Contois, et al.
Diagnostics (Basel, Switzerland)
|
August 29, 2024
PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology
Stephanie M Eastwood, Matthew R Meyer, Kristopher M Kirmess, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 20, 2021
The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis
Kristopher M Kirmess, Matthew R Meyer, Mary S Holubasch, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
The Journal of Nutritional Biochemistry
|
May 23, 2008
Carbohydrate restriction and dietary cholesterol distinctly affect plasma lipids and lipoprotein subfractions in adult guinea pigs
Moises Torres-Gonzalez, Jose O Leite, Jeff S Volek, et al.
The Journal of Nutrition
|
January 21, 2006
Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men
Richard J Wood, Jeff S Volek, Yanzhu Liu, et al.
Clinical Chemistry
|
January 27, 2009
Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
John H Contois, Joseph P McConnell, Amar A Sethi, et al.
Circulation. Cardiovascular Quality and Outcomes
|
April 14, 2011
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk
Allan D Sniderman, Ken Williams, John H Contois, et al.
The Journal of Nutrition
|
September 22, 2006
A combination therapy including psyllium and plant sterols lowers LDL cholesterol by modifying lipoprotein metabolism in hypercholesterolemic individuals
Sudeep Shrestha, Jeff S Volek, Jay Udani, et al.
Clinical Chemistry
|
February 7, 2013
Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices
, Thomas G Cole, John H Contois, et al.
Clinical Chemistry
|
September 20, 2013
In reply
Thomas G Cole, John H Contois, Gyorgy Csako, et al.
JAMA
|
August 21, 2007
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women
Erik Ingelsson, Ernst J Schaefer, John H Contois, et al.
Diagnostics (Basel, Switzerland)
|
August 29, 2024
PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology
Stephanie M Eastwood, Matthew R Meyer, Kristopher M Kirmess, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 20, 2021
The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis
Kristopher M Kirmess, Matthew R Meyer, Mary S Holubasch, et al.
Page
of 3